FR3048359B1 - Utilisation d’au moins un filtre uva long pour prevenir l’apparition de sensations dysesthesiques - Google Patents

Utilisation d’au moins un filtre uva long pour prevenir l’apparition de sensations dysesthesiques Download PDF

Info

Publication number
FR3048359B1
FR3048359B1 FR1651729A FR1651729A FR3048359B1 FR 3048359 B1 FR3048359 B1 FR 3048359B1 FR 1651729 A FR1651729 A FR 1651729A FR 1651729 A FR1651729 A FR 1651729A FR 3048359 B1 FR3048359 B1 FR 3048359B1
Authority
FR
France
Prior art keywords
once
prevent
uva filter
sensations
long uva
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1651729A
Other languages
English (en)
Other versions
FR3048359A1 (fr
Inventor
Laurent Marrot
Jean Philippe Belaidi
Laurence Denat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR1651729A priority Critical patent/FR3048359B1/fr
Publication of FR3048359A1 publication Critical patent/FR3048359A1/fr
Application granted granted Critical
Publication of FR3048359B1 publication Critical patent/FR3048359B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne l'utilisation cosmétique d'au moins un filtre UV-A long pour prévenir l'apparition de sensations dysesthésiques. La présente invention vise principalement à proposer un nouvel actif pour prévenir l'apparition de sensations dysesthésiques.
FR1651729A 2016-03-01 2016-03-01 Utilisation d’au moins un filtre uva long pour prevenir l’apparition de sensations dysesthesiques Active FR3048359B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1651729A FR3048359B1 (fr) 2016-03-01 2016-03-01 Utilisation d’au moins un filtre uva long pour prevenir l’apparition de sensations dysesthesiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1651729A FR3048359B1 (fr) 2016-03-01 2016-03-01 Utilisation d’au moins un filtre uva long pour prevenir l’apparition de sensations dysesthesiques

Publications (2)

Publication Number Publication Date
FR3048359A1 FR3048359A1 (fr) 2017-09-08
FR3048359B1 true FR3048359B1 (fr) 2020-11-06

Family

ID=56555458

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1651729A Active FR3048359B1 (fr) 2016-03-01 2016-03-01 Utilisation d’au moins un filtre uva long pour prevenir l’apparition de sensations dysesthesiques

Country Status (1)

Country Link
FR (1) FR3048359B1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4154719B2 (ja) * 2002-07-10 2008-09-24 チバ ホールディング インコーポレーテッド 化粧品用途のためのメロシアニン誘導体
GB2433499A (en) * 2005-12-20 2007-06-27 Ciba Sc Holding Ag Merocyanine derivatives useful as UV absorbing agents
FR2967065A1 (fr) * 2010-11-09 2012-05-11 Oreal Utilisation d'extrait de grenade pour prevenir et/ou traiter les sensations dysesthesiques des peaux et/ou des cuirs chevelus intolerants et/ou irritables
WO2013010590A1 (fr) * 2011-07-21 2013-01-24 L'oreal Composition cosmétique et/ou dermatologique contenant un dérivé de mérocyanine qui comprend des groupes polaires spécifiques constitués de fonctionnalités hydroxyle et éther

Also Published As

Publication number Publication date
FR3048359A1 (fr) 2017-09-08

Similar Documents

Publication Publication Date Title
GEP20237506B (en) Pcsk9 antagonist compounds
MA52486A (fr) Pyridazinones utilisés en tant qu'inhibiteurs de parp7
AR111208A1 (es) ANTICUERPOS ANTI-PÉPTIDO b AMILOIDE N3PGLU Y SUS USOS
MA42109B1 (fr) Amides hétérocycliques utilisés en tant qu'inhibiteurs de kinase
BR112015029969A2 (pt) tratamento de câncer usando moduladores de isoformas quinase pi3
CL2019003126A1 (es) Métodos de tratamiento mediante el uso de un compuesto inhibidor de jak.
PE20180024A1 (es) Triazolopirazinonas como inhibidores de pde1
PE20150617A1 (es) Formas solidas de 3-(4-((4-(morfolinometil)bencil)oxi)-1-oxoisoindolin-2-il)piperidin-2,6-diona o un estereoisomero del mismo, de sus sales, y composiciones que comprenden las mismas
MA38957B1 (fr) Combinaisons d'anti-inflammatoire non stéroïdien (ains) et de ligand des récepteurs sigma
MA50013A (fr) Analogues de benzoazépine utilisés en tant qu'agents inhibiteurs de la tyrosine kinase de bruton
EA201990400A1 (ru) Соединения и композиции и их применение
NI202100018A (es) Moduladores de la expresión de pnpla3
MA47736B1 (fr) Pyrimidopyrimidinones utiles en tant qu'inhibiteurs de la kinase wee-1
CL2019002574A1 (es) Moduladores de la expresión de pcsk9.
EA202092748A1 (ru) Модуляторы экспрессии apol1
FR3060376B1 (fr) Agent et procede pour la mise en forme temporaire de fibres keratiniques
CL2019001618A1 (es) Uso de compuestos de carbamato para prevención, alivio o tratamiento del trastorno bipolar.
FR3045351B1 (fr) Agent pour la mise en forme temporaire des fibres keratiniques avec conservateur iii
CL2020000337A1 (es) Uso terapéutico o no terapéutico de protozoos del género willaertia como fungistático y/o fungicida.
MA41809B1 (fr) Biotine pour le traitement de la sclérose latérale amyotrophique
CL2019003037A1 (es) Combinaciones fungicidas.
FR3048359B1 (fr) Utilisation d’au moins un filtre uva long pour prevenir l’apparition de sensations dysesthesiques
EP4371613A3 (fr) Composés destinés à être utilisés dans le traitement de la douleur oculaire
CA2909622C (fr) Composes donneurs d'oxyde nitrique a base de quinone a usage ophtalmique
EA201990550A1 (ru) Офтальмологический препарат, включающий азоловое соединение

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20170908

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9